Evidence map›Paper›PMID 15082917›Full record

ReviewJournal of mammary gland biology and neoplasia2004

Transcriptional control of the cell cycle in mammary gland development and tumorigenesis.

Ricardo D Coletta, Paul Jedlicka, Arthur Gutierrez-Hartmann, Heide L Ford

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of mammary gland biology and neoplasia, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Electrical detection of specific versus non-specific binding events in breast cancer cells.Proceedings of SPIE--the International Society for Optical Engineering · 2012
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Ricardo D ColettaDepartment of Obstetrics and Gynecology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
Paul Jedlicka
Arthur Gutierrez-Hartmann
Heide L Ford
University of Colorado Health · USUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Colorado Denver · US

Funding

Role of Six1 in EMT and Tumor ProgressionR01CA095277 · NCI · UNIVERSITY OF COLORADO DENVER · PI FORD, HEIDE L. · 2002 to 2017
$4.3M
NCI NIH HHS 1R01CA095277-01NCI NIH HHS R01 CA095277
6 · The paper itself

Abstract

Over the past several years it has become increasingly evident that normal development and cancer share many properties. Both processes involve alterations in cell proliferation and differentiation, cell death, neovascularization, and cell motility and invasion. Thus, genes involved in normal development are frequently utilized in neoplasia. During development, numerous transcriptional regulatory mechanisms are used to ensure tight control over cellular proliferation. In this review we focus on a number of transcription factor families (homeobox, STAT, and Ets), and on inhibitors of transcription factors (Id), which have been implicated in controlling the cell cycle not only in normal mammary gland development but also in breast tumorigenesis.

Indexed as

Cell CycleCell Transformation, NeoplasticGenes, HomeoboxBreast NeoplasmsCell DeathCell ProliferationFemaleGene Expression Regulation, DevelopmentalHumansMammary Glands, HumanNeovascularization, PathologicTranscription FactorsTranscription Factors

Identifiers

PMID15082917
OpenAlexW1995800107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.